Diagnostic approaches for cholangiocarcinoma

World Journal of Gastroenterology

Volumn 14, Issue 26, 2008, Pages 4131-4136

  Weber, Andreas ^a   Schmid, Roland M ^a   Prinz, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Brush cytology; Cholangiocarcinoma; Diagnosis; Forceps biopsy

Indexed keywords

ASPIRATION BIOPSY; BILE DUCT CARCINOMA; BILIARY TRACT ENDOSCOPY; BIOCHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FIBERSCOPE ENDOSCOPY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; BILE DUCT TUMOR; CHOLANGIOGRAPHY; INTRAHEPATIC BILE DUCT;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOGRAPHY; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; ENDOSONOGRAPHY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 54049138509     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4131     Document Type: Review

References (65)

1. Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988; 12: 39-47
2. Olhes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004; 66: 167-179
3. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 204-207
4. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993; 68: 874-879
5. Nakeeb A, Upsett PA, Lillemoe KD, Fox-larbor MK, Coleman J, Cameron JL, Pitt HA. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 1996; 171: 147-152; discussion 152-153
6. Lamerz R. Role of tumour markers, cytogenetics. Ann Oncol 1999; 10 Suppl 4:145-149
7. Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig Dis Sci 1988; 33: 1223-1225
8. John AR, Haghighi KS, Taniere P, Esmat ME, Tan YM, Bramhall SR. Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis? Dig Surg 2006; 23: 319-324
9. Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 2004; 24: 139-154
10. Sharma MP, Ahuja V. Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective. Trop Gastroenterol 1999; 20: 167-169
11. Robledo R, Muro A, Prieto ML. Extrahepatic bile duct carcinoma: US characteristies and accuracy in demonstration of tumors. Radiology 1996; 198: 869-873
12. Nicolau C, Vilana R, Catala V, Bianchi L, Gilabert R, Garcia A, Bru C. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 2006; 186: 158-167
13. Bartolotta TV, Taibbi A, Galia M, Runza G, Matranga D, Midiri M, Lagalla R. Characterization of hypoechoic focal hepatic lesions in patients with fatty liver, diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol 2007; 17: 650-661
14. Celli N, Gaiani S, Piscaglia F, Zironi G, Camaggi V, Leoni S, Righini R, Bolondi L. Charactcrization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 2007; 19: 3-14
15. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, Liang JY. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006; 34: 261-272
16. Xu HX, Lu MD, Liu GJ, Xie XY, Xu ZF, Zheng YL, Liang JY. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and Sono Vue: initial experience. J Ultrasound Med 2006; 25: 23-33
17. Tillich M, Mischinger HJ, Preisegger KH, Rabl H, Szolar DH. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR Am J Roentgenol 1998; 171: 651-658
18. Hann LE, Getrajdman GI, Brown KT, Bach AM, Teitcher JB, Fong Y, Blumgart LH. Hepatic lobar atrophy: assoeiation with ipsilateral portal vein obstruction. AJR Am J Roentgenol 1996; 167: 1017-1021
19. Yamashita Y, Takahashi M, Kanazawa S, Charnsangavej C, Wallace S. Parenchymal changes of the liver in cholangiocarcinoma: CT evaluation. Gastrointest Radiol 1992; 17: 161-166
20. Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, Curley SA. High-resolution computed tomography accurately predicts rescetability in hilar cholangiocarcinoma. Am J Surg 2007; 193: 702-706
21. Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 2004; 24: 155-164
22. Manfredi R, Masselli G, Maresca G, Brizi MG, Vecchioli A, Marano P. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom lmaging 2003; 28: 319-325
23. Masselli G, Gualdi G. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom lmaging 2008; 33: 444-451
24. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H. Guidelines for the diagnošis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51 Supplo: 6:V11-V19
25. Zidi SH, Prat F, Le Guen O, Rondeau Y, Pelletier G. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut 2000; 46: 103-106
26. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004; 8: 90-97
27. Lee JD, Yang WI, Park YN, Kim KS, Choi JS, Yun M, Ko D, Kim TS, Cho AE, Kim HM, Han KH, Im SS, Ahn YH, Choi CW, Park JH. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake. J Nucl Med 2005; 46: 1753-1759
28. Reinhardt MJ, Strunk H, Gerhardt T, Roedel R, Jaeger U, Bucerius J, Sauerbruch T, Biersack HJ, Dumoulin FL. Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies. J Nucl Med 2005; 46: 1158-1163
29. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW. Evaluation of benign vs malignant hepatic tesions with positron emission tomography. Arch Surg 1998; 133: 510-515; discussion 515-516
30. Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 2003; 30: 1467-1472
31. Wakabayashi H, Akamoto S, Yachida S, Okano K, Izuishi K, Nishiyama Y, Maeta H. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture. Eur J Surg Oncol 2005; 31: 1175-1179
32. Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, Lee JH, Kim KA, Kim AY, Kim PN, Lee MC, Ha HK. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004; 233: 234-240
33. Rosch T, Meining A, Fruhmorgen S, Zillinger C, Schusdziarra V, Hellerhoff K, Classen M, Helmberger H. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 2002; 55: 870-876
34. Zuidema GD, Cameron JL, Sitzmann JV, Kadir S, Smith GW, Kaufman SL, White Rl Jr. Percutaneous transhepatic management of complex biliary problems. Ann Surg 1983; 197: 584-593
35. Harrington DP, Barth KH, Maddrey WC, Kaufman SL, Cameron JL. Percutaneously placed biliary stents in the management of malignant biliary obstruction. Dig Dis Sci 1979; 24: 849-857
36. Mueller PR, van Sonnenberg E, Ferrucci JT Jr. Percutaneous biliary drainage: technical and catheter-related problems in 200 procedures. AJR Am J Roentgenol 1982; 138: 17-23
37. Yee AC, Ho CS. Complications of percutaneous biliary drainage: benign vs malignant diseases. AJR Am J Roentgenol 1987; 148: 1207-1209
38. Clark RA, Mitchell SE, Colley DP, Alexander E. Percutaneous catheter biliary decompression. AJR Am J Roentgenol 1981; 137: 503-509
39. Carrasco CH, Zornoza J, Bechtel WJ. Malignant biliary obstruction: complications of percutaneous biliary drainage. Radiology 1984; 152: 343-346
40. Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile duct lesions. Gastrointest Endosc 2005; 62: 374-382
41. Tamada K, Inui K, Menzel J. Intraductal ultrasonography of the bile duct system. Endoscopy 2001; 33: 878-885
42. Levy MJ, Vazquez-Sequeiros E, Wiersema MJ. Evaluation of the pancreaticobiliary ductal systems by intraductal US. Gastrointest Endosc 2002; 55: 397-408
43. Tamada K, ldo K, Ueno N, Kimura K, lchiyama M, Tomiyama T. Preoperative staging of extrahepatic bile duct cancer with intraductal ultrasonographv. Am J Gastroenterol 1995; 90: 239-246
44. Tamada K, Ido K, Ueno N, Ichiyama M, Tomiyama T, Nishizono T, Wada S, Noda T, Tano S, Aizawa T. Assessment of portal vein invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995; 27: 573-578
45. Tamada K, Ido K, Ueno N, Ichiyama M, Tomiyama T, Nishizono T, Wada S, Noda T, Tano S, Aizawa T. Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995; 27: 579-583
46. Tamada K, Nagai H, Yasuda Y, Tomiyama T, Ohashi A, Wada S, Kanai N, Satoh Y, Ido K, Sugano K. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. Gastrointest Endosc 2001; 53: 300-307
47. Stavropoulos S, Larghi A, Verna E, Battezzati P, Stevens P. Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography. Endoscopy 2005; 37: 715-721
48. Tamada K, Tomiyama T, Wada S, Ohashi A, Satoh Y, Ido K, Sugano K. Endoscopic transpapillary bile duct biopsy with the combination of intraductal ultrasonography in the diagnosis of biliary strictures. Gut 2002; 50: 326-331
49. Vazquez-Sequeiros E, Baron TH, Clain JE, Gostout CJ, Norton ID, Petersen BT, Levy MJ, Jondal ML, Wiersema MJ. Evaluation of indeterminate bile duct strictures by intraductal US. Gastrointest Endosc 2002; 56: 372-379
50. Eloubeidi MA, Chen VK, Jhala NC, Eltoum IE, Jhala D, Chhieng DC, Syed SA, Vickers SM, Mel Wilcox C. Endoscopic ultrasound-guided tine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2004; 2: 209-213
51. Byrne MF, Gerke H, Mitchell RM, Stiffler HL, McGrath K, Branch MS, Baillis J, jowell PS. Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions. Endoscopy 2004; 36: 715-719
52. Brugge WR. Endoscopic techniques to diagnose and manage biliary tumors. J Clin Oncol 2005; 23: 4561-4565
53. Osnes M, Serck-Hanssen A, Myren J. Endoscopic retrograde brush cytology (ERBC) of the biliary and pancreatic ducts. Scand J Gastroenterol 1975; 10: 829-831
54. Jailwala J, Fogel EL, Sherman S, Gottlieb K, Flueckiger J, Bucksot LG, Lehman GA. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 2000; 51: 383-390
55. Mansfield JC, Griffin SM, Wadehra V, Matthewson K. A prospective evaluation of eytology from biliary strictures. Gut 1997; 40: 671-677
56. Macken E, Drijkoningen M, Van Aken E, Van Steenbergen W. Brush cytology of ductal strictures during ERCP. Acta Gastroenterol Belg 2000; 63: 254-259
57. Ponchon T, Gagnon P, Berger F, Labadie M, Liaras A, Chavaillon A, Bory R. Value of endobiliary brush cytology and biopsies for the diaginosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 1195; 42: 565-572
58. Pugnese V, Canio M, Nicolo G, Saccomanno S, Gatteschi B. Endoscopic retrograde forceps blopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 1995; 42: 520-526
59. Kubota Y, Yamaguchi T, Tani K, Takaoka M, Fujimura K, Ogura M, Yamamoto S, Mizuno T, Inoue K. Anatomical variation of pancreatobiliary ducts in biliary stone diseases. Abdom lmaging 1993; 18: 145-149
60. Weber A, von Weyhern C, Fend F, Schneider J, Neu B, Meining A, Weidenbach H, Schmid RM, Prinz C. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol 2008; 14: 1097-110l
61. Moreno Luna LE, Kipp B, Halling KC, Sebo TJ, Kremers WK, Roberts LR, Barr Fritcher EG, Levy MJ, Gores GJ. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 2006; 131:1064-1072
62. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, de Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004; 99: 1675-1681
63. Zellweger T, Benz G, Cathomas G, Mihatsch MJ, Sulser T, Gasser TC, Bubendorf L. Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer, lnt J Cancer 2006; 119: 1660-1665
64. Wamsteker EJ, Anderson MA. Fluorescence in situ hybridization for the detection of malignant bile duct strictures: has FISH found a new pond? Am J Gastroenterol 2004; 99: 1682-1683
65. Berquist A Tribukait B, Claumann H, Breeme U, Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duet strictures in primary sclerosing cholangitis? J Hepatot 2000; 33: 873-877